PATIENTS (ARCC) TREATED WITH MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR (MTORI) THERAPY FOLLOWING FIRST-LINE PAZOPANIB (PAZ) IN A US COMMUNITY ONCOLOGY SETTINGThomas E Hutson,Nicholas J Vogelzang,Debajyoti Bhowmik,Debra Rembert,Eric Jonaschmag(2014)引用 23|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要